Literature DB >> 7971976

Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.

Y Lee1, H Hirose, M Ohneda, J H Johnson, J D McGarry, R H Unger.   

Abstract

Hyperinsulinemia, loss of glucose-stimulated insulin secretion (GSIS), and peripheral insulin resistance coexist in non-insulin-dependent diabetes mellitus (NIDDM). Because free fatty acids (FFA) can induce these same abnormalities, we studied their role in the pathogenesis of the NIDDM of obese Zucker diabetic fatty (ZDF-drt) rats from 5 weeks of age (before the onset of hyperglycemia) until 14 weeks. Two weeks prior to hyperglycemia, plasma FFA began to rise progressively, averaging 1.9 +/- 0.06 mM at the onset of hyperglycemia (P < 0.001 vs. controls). At this time GSIS was absent and beta-cell GLUT-2 glucose transporter was decreased. The triacylglycerol content of prediabetic islets rose to 10 times that of controls and was correlated with plasma FFA (r = 0.825; P < 0.001), which, in turn, was correlated with the plasma glucose concentration (r = 0.873; P < 0.001). Reduction of hyperlipacidemia to 1.3 +/- 0.07 mM by pair feeding with lean littermates reduced all beta-cell abnormalities and prevented hyperglycemia. Normal rat islets that had been cultured for 7 days in medium containing 2 mM FFA exhibited increased basal insulin secretion at 3 mM glucose, and first-phase GSIS was reduced by 68%; in prediabetic islets, first-phase GSIS was reduced by 69% by FFA. The results suggest a role for hyperlipacidemia in the pathogenesis of NIDDM; resistance to insulin-mediated antilipolysis is invoked to explain the high FFA despite hyperinsulinemia, and sensitivity of beta cells to hyperlipacedemia is invoked to explain the FFA-induced loss of GSIS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971976      PMCID: PMC45129          DOI: 10.1073/pnas.91.23.10878

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The in vitro perfused pancreas.

Authors:  G M Grodsky; R E Fanska
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

4.  Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance.

Authors:  G C Weir
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

5.  Preliminary characterization of calcium binding in islet-cell plasma membranes.

Authors:  S P Naber; J M McDonald; L Jarett; M L McDaniel; C W Ludvigsen; P E Lacy
Journal:  Diabetologia       Date:  1980-11       Impact factor: 10.122

6.  The metabolism of lipids in mouse pancreatic islets. The oxidation of fatty acids and ketone bodies.

Authors:  C Berne
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

7.  A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

Authors:  M W McGowan; J D Artiss; D R Strandbergh; B Zak
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

8.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  High content of mitochondrial glycerol-3-phosphate dehydrogenase in pancreatic islets and its inhibition by diazoxide.

Authors:  M J MacDonald
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

10.  Stimulation of insulin secretion by infusion of free fatty acids.

Authors:  S R Crespin; W B Greenough; D Steinberg
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

View more
  222 in total

1.  Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.

Authors:  I Briaud; J S Harmon; C L Kelpe; V B Segu; V Poitout
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.

Authors:  G Paolisso; P A Tataranni; J E Foley; C Bogardus; B V Howard; E Ravussin
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

3.  Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity.

Authors:  Sarah Navina; Chathur Acharya; James P DeLany; Lidiya S Orlichenko; Catherine J Baty; Sruti S Shiva; Chandra Durgampudi; Jenny M Karlsson; Kenneth Lee; Kyongtae T Bae; Alessandro Furlan; Jaideep Behari; Shiguang Liu; Teresa McHale; Larry Nichols; Georgios Ioannis Papachristou; Dhiraj Yadav; Vijay P Singh
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

4.  Changes of very low-density lipoprotein concentration in hepatic blood from cows with fasting-induced hepatic lipidosis.

Authors:  Shin Oikawa; Yuko Mizunuma; Yukari Iwasaki; Mohamed Tharwat
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

5.  Evidence for protein-mediated fatty acid efflux by adipocytes.

Authors:  A H Henkin; A M Ortegon; S Cho; W-J Shen; A Falcon; F B Kraemer; S-J Lee; A Stahl
Journal:  Acta Physiol (Oxf)       Date:  2011-10-25       Impact factor: 6.311

6.  Ectopic fat deposition in prediabetic overweight and obese minority adolescents.

Authors:  Claudia M Toledo-Corral; Tanya L Alderete; Houchun H Hu; Krishna Nayak; Sherryl Esplana; Ting Liu; Michael I Goran; Marc J Weigensberg
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

7.  Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.

Authors:  M T Pedrini; M Kranebitter; A Niederwanger; S Kaser; J Engl; P Debbage; L A Huber; J R Patsch
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

8.  Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats.

Authors:  Ellen Q Wang; Ho-Leung Fung
Journal:  AAPS PharmSci       Date:  2002

9.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

Review 10.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.